Recapitulation of Neuropsychiatric Behavioral Features in Mice Using Acute Low-dose MK-801 Administration
- Author:
Darine Froy N MABUNGA
1
;
Donghyun PARK
;
Onjeon RYU
;
Schley T VALENCIA
;
Keremkleroo Jym L ADIL
;
Seonmin KIM
;
Kyoung Ja KWON
;
Chan Young SHIN
;
Se Jin JEON
Author Information
- Publication Type:Original Article
- Keywords: MK-801; Behavioral domains; Neuropsychiatric disorders; Animal model
- MeSH: Animals; Avoidance Learning; Cognition; Dizocilpine Maleate; Impulsive Behavior; Mice; Models, Animal; N-Methylaspartate
- From:Experimental Neurobiology 2019;28(6):697-708
- CountryRepublic of Korea
- Language:English
- Abstract: Despite some innate limitations, animal models are a potent investigative tool when used to model specific symptoms of a disorder. For example, MK-801, an N-methyl-D-aspartate receptor antagonist, is used as a pharmacological tool to induce symptoms found in some neuropsychiatric disorders. However, a close examination of literature suggests that the application window of MK-801 doses is relatively narrow between individual behavioral paradigms, necessitating careful characterization of the evoked behavioral aberrations and the doses used to induce them. Moreover, variation in behaviors depending on the animal strain, gender of the subject, and the timing of administration is observed, making it difficult to compare the behavioral characteristics reported in different studies. We aim to characterize the behavioral aberrations induced by different doses of MK-801 in CD-1 mice and create a ready reference for future studies. We used CD-1 mice to recapitulate behavioral impairments resulting from acute administration of MK-801. In 0.1 mg kg⁻¹, we observed diminished spontaneous alteration during the Y-maze test, while 0.12 mg kg⁻¹ resulted in hyperlocomotion and social deficit. Mice treated with 0.2 and 0.3 mg kg⁻¹ of MK-801 demonstrated a decreased self-grooming. Finally, all doses significantly impaired cliff avoidance behaviors suggesting increased impulsivity. These results affirm that MK-801 can effectively model various symptoms of different neuropsychiatric disorders in a dose-dependent manner. The observed sensitivity against spatial-memory impairment and impulsive behaviors at low concentration of MK-801 suggest that MK801 may modulate cognitive function and impulsivity in even lower concentration before it can modulate other behavioral domains.
